Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece.
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age55-85
SponsorAristotle University Of Thessaloniki
About this trial
Objective: The purpose of this study is to assess the psychometric qualities of the Montreal Cognitive Assessment (MoCA) version 8.x in Greek, including the MoCA-MIS. We intend to examine the tool's reliability (internal consistency, test-retest reliability) and validity (construct validity, concurrent validity, and known-group validity).
Aim: The findings will support the tool's application for early cognitive impairment identification in clinical and research settings.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participants between the ages of 55-85
Fluent in Greek to avoid misunderstandings during the assessment
Participants must be able to provide informed consent
Disqualifiers
History of severe psychiatric or neurological disorders apart from MCI/dementia
Patients having acute medical illnesses
Patients having severe hearing and/or visual impairments
Trial population
* 50-100 Cognitively Healthy Adults * 50-75 MCI Patients * 50-75 Demented Patients The participants of this study will be recruited from the outpatient clinic of the 3rd Department of Psychiatry School of Medicine, General University Hospital of Thessaloniki "AHEPA".
Trial design
Design model
Cohort
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
250 Participants
are grouped into 3 trial groupsGroup A: Control Group
Group B: Group were patients have a MCI diagnosis
Group C: Demented patients
Trial outcomes
Primary outcomes
1
The Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece.
Time frame
From enrollment to the end of the follow-up period at 4 weeks.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Aristotle University Of Thessaloniki
Lead sponsor
MoCA Clinic and Institute
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: